Alex has a special interest in electronic clinical outcome assessments (eCOA) and has served as Co-Chair of the Critical Path Institute’s (C-Path) ePRO subcommittee. In her HEOR role, she was responsible for the strategic development and delivery of a portfolio of economic and quality of life evidence in support of regulatory submissions and commercialization mainly within rare diseases, e.g., Duchenne muscular dystrophy and sickle cell disease. #Icd 10 code for dm1 with hypoglycemia proShe worked for five years in the PRO Center at Pfizer where she was responsible for the selection, development, validation, implementation, analysis, and interpretation of COAs across the product lifecycle across various therapeutic areas including urology, pain, diabetes, oncology, and women’s health. with a focus on clinical outcome assessments (COAs) and health economics outcomes research (HEOR). Alex has 10 years pharmaceutical industry outcomes research experience at Pfizer Inc. Introduction to Patient Reported OutcomesĪlex recently joined Clinical Outcomes Solutions (COS) as Director of Clinical Outcome Assessments (COA). Martin is contributing to national policy research on opioids and health care financing and has recently lead an international effort to improve the conduct and reporting of CER observational research organized by three national associations: ISPOR, NPC, AMCP. Martin has over 90 peer-reviewed manuscripts published, which have been collectively cited over 4000 times, and his work has been funded by NIH, AHRQ, VA, and a variety of research foundations as well as partnerships with the pharmaceutical industry. He conducts policy analyses, and develops cost effectiveness models and has contributed to the understanding of the opioid epidemic. Martin’s research efforts have focused on conducting retrospective observational comparative effectiveness and economic analyses using large administrative data sets and national health surveys. Martin received his PharmD from the University of Illinois and earned his PhD in Pharmacy Care Administration from the University of Georgia. #Icd 10 code for dm1 with hypoglycemia professionalThe Pharmaceutical Evaluation and Policy Division offers graduate and professional instruction and conducts research in pharmacoeconomics, patient reported outcomes, pharmaceutical economics, and large health claims data base analysis. Bradley Martin is currently Professor and was the founding head of the Pharmaceutical Evaluation and Policy (PEP) Division at the University of Arkansas for Medical Sciences College of Pharmacy.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |